Trial Profile
Laparoscopic ileocolic resection versus infliximab treatment of recurrent distal ileitis in Crohn's disease: a randomized multicenter trial (LIR!C-trial).
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 22 Oct 2015
Price :
$35
*
At a glance
- Drugs Infliximab (Primary) ; Prednisolone
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms LIRIC
- 25 Aug 2013 Status changed from completed to recruiting as reported by Netherlands Trial Register record.
- 30 Jul 2012 New trial record